| Pubmed ID |
Author | Year | Title |
21189639 |
Zhu H | 2001 | [The change of malondialdehyde and superoxide dismutase in apoptotic granulosa cell of rat PCO]. |
21190873 |
Yasar L | 2011 | Serum adiponectin levels in high school girls with polycystic ovary syndrome and hyperandrogenism. |
21190977 |
Tan BK | 2011 | Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells. |
21190980 |
Ma RC | 2011 | Sonographic measurement of mesenteric fat predicts presence of fatty liver among subjects with polycystic ovary syndrome. |
21191832 |
Chen ZJ | 2010 | Polycystic ovary syndrome. |
21192531 |
Gebel E | 2010 | A new shine on an old med. The story of metformin's past, present, and possible future. |
21193185 |
Veras AB | 2011 | Sexual dysfunction in patients with polycystic ovary syndrome: clinical and hormonal correlations. |
21193187 |
Ladson G | 2011 | The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study. |
21193188 |
Soyman Z | 2011 | Serum paraoxonase 1 activity, asymmetric dimethylarginine levels, and brachial artery flow-mediated dilatation in women with polycystic ovary syndrome. |
21193545 |
Kandaraki E | 2011 | Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. |
21193614 |
Bloomgarden ZT | 2011 | The American Diabetes Association's 57th annual advanced postgraduate course: diabetes risk, vitamin D, polycystic ovary syndrome, and obstructive sleep apnea. |
21194310 |
Stovall DW | 2011 | Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome. |
21196376 |
Lapointe E | 2011 | WNT signaling and the regulation of ovarian steroidogenesis. |
21197149 |
Kahal H | 2011 | Pharmacological treatment of obesity in patients with polycystic ovary syndrome. |
21198949 |
Chen W | 2011 | Acne-associated syndromes: models for better understanding of acne pathogenesis. |
21199038 |
de Sousa G | 2011 | Relationships between polysomnographic variables, parameters of glucose metabolism, and serum androgens in obese adolescents with polycystic ovarian syndrome. |
21199270 |
Tan BK | 2011 | Phosphoprotein enriched in diabetes gene product (Ped/pea-15) is increased in omental adipose tissue of women with the polycystic ovary syndrome: ex vivo regulation of ped/pea-15 by glucose, insulin and metformin. |
21204821 |
Verrotti A | 2011 | Antiepileptic drugs, sex hormones, and PCOS. |
21206344 |
Young IS | 2010 | Lipid metabolism. |
21207332 |
Smitz JE | 2011 | The promise of in vitro maturation in assisted reproduction and fertility preservation. |
21209024 |
Pellatt LJ | 2011 | Phosphorylation and activation of AMP-activated protein kinase (AMPK) by metformin in the human ovary requires insulin. |
21209031 |
Luque-Ram?rez M | 2011 | Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome. |
21209034 |
Yang S | 2011 | Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance. |
21209036 |
Rice S | 2011 | Action of metformin on the insulin-signaling pathway and on glucose transport in human granulosa cells. |
21209881 |
Eriksen M | 2010 | Insulin resistance is not conserved in myotubes established from women with PCOS. |
21210134 |
Ashrafi M | 2011 | The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety. |
21210850 |
Saha L | 2012 | Pharmacotherapy of polycystic ovary syndrome--an update. |
21210872 |
Penaforte FR | 2011 | Upper trunk fat assessment and its relationship with metabolic and biochemical variables and body fat in polycystic ovary syndrome. |
21213521 |
Sukcharoen N | 2004 | Management ofanovulatory infertility associated with polycystic ovary syndrome (PCOS). |
21213522 |
Weerakiet S | 2004 | Polycystic ovary syndrome and the metabolic syndrome. |
21216086 |
Daghestani MH | 2011 | Circulating ghrelin levels and the polycystic ovary syndrome: correlation with the clinical, hormonal and metabolic features. |
21221823 |
de Sousa G | 2012 | The impact of insulin resistance and hyperandrogenemia on polysomnographic variables in obese adolescents with polycystic ovarian syndrome. |
21228340 |
Yang X | 2011 | Cryptotanshinone reverses reproductive and metabolic disturbances in prenatally androgenized rats via regulation of ovarian signaling mechanisms and androgen synthesis. |
21231824 |
Moini A | 2011 | A possible role for familial thrombophilia in women with polycystic ovarian syndrome. |
21232840 |
M?nsson M | 2011 | Sexuality and psychological wellbeing in women with polycystic ovary syndrome compared with healthy controls. |
21233108 |
Jinno M | 2011 | Advanced glycation end-products accumulation compromises embryonic development and achievement of pregnancy by assisted reproductive technology. |
21234853 |
Cho LW | 2011 | Insulin resistance variability in women with anovulatory and ovulatory polycystic ovary syndrome, and normal controls. |
21240175 |
Akhter S | 2011 | Characteristics of infertile couples. |
21243502 |
Tena G | 2011 | Ovarian morphology and endocrine function in polycystic ovary syndrome. |
21244650 |
Yang Y | 2011 | Is interleukin-18 associated with polycystic ovary syndrome? |
21247239 |
Khattab S | 2011 | Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study. |
21247501 |
Qin Y | 2011 | Association of basal serum testosterone levels with ovarian response and in vitro fertilization outcome. |
21247558 |
Wild RA | 2011 | Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. |
21247566 |
Kilicdag EB | 2011 | Polycystic ovary syndrome and increased polyp numbers as risk factors for malignant transformation of endometrial polyps in premenopausal women. |
21251033 |
Baranova A | 2011 | Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease. |
21252242 |
Wickham EP 3rd | 2011 | Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome. |
21252248 |
Manner?s-Holm L | 2011 | Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome. |
21256780 |
In-Iw S | 2011 | Adolescent women and obesity. |
21257877 |
Pectasides M | 2011 | Diabetes revealed: multisystem danger. |
21261118 |
Vankov? M | 2010 | [Extremely low SHBG level in consequence of Pro156Leu SHBG polymorphism--case reports of two women with polycystic ovary syndrome]. |
21262361 |
Sander VA | 2011 | Alterations of folliculogenesis in women with polycystic ovary syndrome. |
21262477 |
Bronstein J | 2011 | Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought. |
21262871 |
Morteza Taghavi S | 2011 | Metformin decreases thyrotropin in overweight women with polycystic ovarian syndrome and hypothyroidism. |
21263450 |
Goodarzi MO | 2011 | Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. |
21269226 |
Wang A | 2011 | Expression of GPR30, ER? and ER? in endometrium during window of implantation in patients with polycystic ovary syndrome: a pilot study. |
21270326 |
Rosencrantz MA | 2011 | Clinical evidence for predominance of delta-5 steroid production in women with polycystic ovary syndrome. |
21270384 |
Phelan N | 2011 | Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial. |
21271150 |
de Resende LO | 2010 | [Concentration of steroid hormones in the follicular fluid of mature and immature ovarian follicles of patients with polycystic ovary syndrome submitted to in vitro fertilization]. |
21271161 |
Soares J?nior JM | 2010 | [The use of combined oral contraceptives in the polycystic ovary syndrome]. |
21271165 |
Gil Junior AB | 2010 | [Adrenal androgen participation in the polycystic ovary syndrome]. |
21272901 |
Roelfsema F | 2011 | Altered multihormone synchrony in obese patients with polycystic ovary syndrome. |
21274294 |
Broder-Fingert S | 2009 | Evaluation of adolescents for polycystic ovary syndrome in an urban population. |
21274726 |
Li Q | 2011 | Common genetic variation in the 3'-untranslated region of gonadotropin-releasing hormone receptor regulates gene expression in cella and is associated with thyroid function, insulin secretion as well as insulin sensitivity in polycystic ovary syndrome patients. |
21275164 |
Wang XJ | 2010 | [Study on the relation between Pi-deficiency pattern and metabolic syndrome in patients with polycystic ovarian syndrome]. |
21277073 |
Yasmin E | 2011 | Effect of dose escalation of metformin on clinical features, insulin sensitivity and androgen profile in polycystic ovary syndrome. |
21277789 |
Cardozo E | 2011 | Metabolic syndrome and oocyte quality. |
21281021 |
Bhathena RK | 2011 | Insulin resistance and the long-term consequences of polycystic ovary syndrome. |
21282199 |
Wang H | 2011 | A common polymorphism in the human aromatase gene alters the risk for polycystic ovary syndrome and modifies aromatase activity in vitro. |
21282692 |
Wilson JF | 2011 | In the clinic. The polycystic ovary syndrome. |
21282820 |
Kong GW | 2011 | Effects of laparoscopic ovarian drilling in treating infertile anovulatory polycystic ovarian syndrome patients with and without metabolic syndrome. |
21283123 |
Grover A | 2011 | Metformin or thiazolidinedione therapy in PCOS? |
21283731 |
Ewens KG | 2011 | FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. |
21285103 |
Wisner KL | 2011 | Valproate prescription prevalence among women of childbearing age. |
21288501 |
Lamb JD | 2011 | Physical activity in women with polycystic ovary syndrome: prevalence, predictors, and positive health associations. |
21294689 |
T?rk??o?lu I | 2011 | Independent predictors of cardiovascular risk in polycystic ovarian syndrome. |
21297382 |
Franconi G | 2011 | Acupuncture in clinical and experimental reproductive medicine: a review. |
21297528 |
Dasanu CA | 2011 | Polycystic ovary syndrome: focus on platelets and prothrombotic risk. |
21298999 |
Hern?ndez-Valencia M | 2010 | [Care of insulin resistance in polycystic ovary syndrome]. |
21299936 |
Truelsen MK | 2011 | [Polycystic ovary syndrome and miscarriage]. |
21300335 |
Escobar-Morreale HF | 2011 | Role of androgen-mediated enhancement of erythropoiesis in the increased body iron stores of patients with polycystic ovary syndrome. |
21300337 |
Bagis T | 2011 | Pregnancy in women with PCOS. |
21300338 |
Morgante G | 2011 | The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen. |
21300343 |
Younis JS | 2011 | Prospective evaluation of basal stromal Doppler studies in women with good ovarian reserve and infertility undergoing in vitro fertilization-embryo transfer treatment: patients with polycystic ovary syndrome versus ovulatory patients. |
21300347 |
Goodarzi MO | 2011 | Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome. |
21306318 |
Vanky E | 2011 | PCOS--what matters in early pregnancy?--data from a cross-sectional, multicenter study. |
21306320 |
Kauffman RP | 2011 | Serum magnesium concentrations and metabolic variables in polycystic ovary syndrome. |
21306324 |
Amer S | 2011 | The impact of insulin resistance on the outcome of laparoscopic ovarian diathermy in women with polycystic ovarian syndrome. |
21306326 |
Abu Hashim H | 2011 | Intrauterine insemination versus timed intercourse with clomiphene citrate in polycystic ovary syndrome: a randomized controlled trial. |
21307134 |
Romualdi D | 2011 | The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome. |
21310628 |
Smith HA | 2011 | A comparison of polycystic ovary syndrome and related factors between lesbian and heterosexual women. |
21311418 |
Dara? E | 2011 | Transvaginal hydrolaparoscopy. |
21311419 |
De Seta F | 2011 | [Proteomic applications in gynecology-obstetrics]. |
21311428 |
Alemzadeh R | 2011 | New adolescent polycystic ovary syndrome perspectives. |
21311712 |
Meyer FP | 2011 | Step down treatment with antiepileptic drugs. |
21314808 |
Sasaki A | 2011 | Increased arterial stiffness in mildly-hypertensive women with polycystic ovary syndrome. |
21316661 |
Yang S | 2011 | Serum complement C3 has a stronger association with insulin resistance than high-sensitivity C-reactive protein in women with polycystic ovary syndrome. |
21316662 |
Moran LJ | 2011 | Diabetes risk score in the diagnostic categories of polycystic ovary syndrome. |
21316865 |
Alfarouk KO | 2011 | Diabetes mellitus type 2 through oncology lens. |
21323584 |
Merkin SS | 2011 | Socioeconomic status and polycystic ovary syndrome. |
21324452 |
Redman LM | 2011 | Aerobic exercise in women with polycystic ovary syndrome improves ovarian morphology independent of changes in body composition. |
Showing 9,301–9,400 of 14,368